resveratrol has been researched along with Wasting Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abrego, J; Attri, KS; Buettner, K; Chaika, NV; Dasgupta, A; Engle, DD; Grandgenett, PM; Graves, G; Hollingsworth, MA; King, RJ; Klute, KA; Mehla, K; Mulder, SE; Mullen, NJ; Murthy, D; Oberley-Deegan, R; Pacheco, CG; Punsoni, M; Rai, I; Reames, BN; Sadoshima, J; Shukla, SK; Singh, PK; Teoh-Fitzgerald, M; Thakur, R; Tuveson, DA; Vernucci, E; Wang, D; Yu, F; Zimmerman, MC | 1 |
| Akamine, A; Hashiguchi, I; Ike, A; Ishida, T; Ishii, Y; Koga, T; Kuramoto, C; Takeda, T; Taketoh, J; Yahata, M; Yamada, H | 1 |
| Chen, JK; Chen, KH; Cheng, ML; Chiu, DT; Jing, YH; Shiao, MS | 1 |
3 other study(ies) available for resveratrol and Wasting Disease
| Article | Year |
|---|---|
SIRT1-NOX4 signaling axis regulates cancer cachexia.
Topics: Adipose Tissue; Animals; Cachexia; Cell Line; Cell Line, Tumor; Disease Models, Animal; Disease Progression; Forkhead Transcription Factors; HEK293 Cells; Humans; Metabolome; Mice; Muscle Fibers, Skeletal; Muscle, Skeletal; Muscular Atrophy; NADPH Oxidase 4; Neoplasms; NF-kappa B; Oxidation-Reduction; Pancreatic Neoplasms; Protein Stability; Reactive Oxygen Species; Resveratrol; Signal Transduction; Sirtuin 1; Wasting Syndrome | 2020 |
Attenuation of 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity by resveratrol: a comparative study with different routes of administration.
Topics: Administration, Oral; Animals; Antioxidants; Biological Availability; Fatty Liver; Injections, Subcutaneous; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Polychlorinated Dibenzodioxins; Receptors, Aryl Hydrocarbon; Resveratrol; Stilbenes; Toxicity Tests; Wasting Syndrome | 2009 |
Resveratrol ameliorates metabolic disorders and muscle wasting in streptozotocin-induced diabetic rats.
Topics: Adenylate Kinase; Animals; Antioxidants; Cytokines; Diabetes Mellitus, Experimental; Drug Evaluation, Preclinical; Male; Metabolic Diseases; Models, Biological; Muscle, Skeletal; Muscular Diseases; NF-kappa B; Rats; Rats, Sprague-Dawley; Resveratrol; Sirtuin 1; Stilbenes; Streptozocin; Wasting Syndrome | 2011 |